Identification of key factors and target analysis of berberine in rectal cancer via network pharmacology
Integrate Medicine · 31.01.2025
DOI: 10.61958/imwk2881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.01.2025. Verfasst von Ting-Ting Zhi. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aimed to perform a comprehensive bioinformatics analysis to identify pharmacological targets in rectal tissue and explore the therapeutic role of berberine (BBR) in rectal cancer (RC).
Methods
Extensive keyword-based searches were conducted across multiple databases, including GeneCards, the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), HERB, and the Encyclopedia of Traditional Chinese Medicine (ETCM), to identify target genes associated with both berberine and RC. Venn analysis was employed to determine overlapping genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were then performed to investigate the biological functions and pathways associated with these genes. Additionally, the protein-protein interaction (PPI) network was constructed to identify the core genes and elucidate potential mechanisms.
Results
Venn analysis identified 85 intersecting genes, among which 10 hub genes were closely related to both RC and BBR: tumor protein p53 (TP53), tumor necrosis factor (TNF), signal transducer and activator of transcription 3 (STAT3), mitogen-activated protein kinase 1 (MAPK1), interleukin-6 (IL-6), Jun proto-oncogene, AP-1 transcription factor subunit (JUN), hypoxia-inducible factor 1 subunit alpha (HIF1A), nuclear factor kappa B subunit 1 (NFKB1), AKT serine/threonine kinase 1 (AKT1), and estrogen receptor 1 (ESR1). Furthermore, our findings suggest that BBR modulates multiple signaling pathways to regulate key gene expression, ultimately inhibiting RC cell proliferation and metastasis.
Conclusions
This study identifies potential pharmacological targets in RC that are modulated by berberine, providing insights into its therapeutic mechanisms and supporting its potential application in RC treatment.
Zitieren
APA
Zhi, T. (2025). Identification of key factors and target analysis of berberine in rectal cancer via network pharmacology. Integrate Medicine. https://doi.org/10.61958/imwk2881
Vancouver
Zhi T. Identification of key factors and target analysis of berberine in rectal cancer via network pharmacology. Integrate Medicine. 2025. doi:10.61958/imwk2881
BibTeX
@article{Zhi2025,
author = {Zhi, Ting-Ting},
title = {Identification of key factors and target analysis of berberine in rectal cancer via network pharmacology},
journal = {Integrate Medicine},
year = {2025},
doi = {10.61958/imwk2881}
}
EUVIMED